Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Hyundai Motor disclosed a correction regarding its participation in the rights issue of its subsidiary 42dot Inc. due to changes in the target company’s business plan. The total acquisition volume was slightly adjusted to 5,093,789 shares valued at approximately KRW 657.10B, with the Phase 3 payment date updated to August 2025.
📊 [Key Disclosure Content & Financial Highlights]
1. Key Correction Details (Participation in 42dot Rights Issue)
- Acquisition Shares: Previously 5,095,446 shares ➔ Revised to 5,093,789 shares (-1,657 shares)
- Acquisition Amount: Previously KRW 657,313,000,000 ➔ Revised to KRW 657,099,000,000 (Approx. KRW 657.10B / -KRW 214M)
- Shares Owned & Equity Ratio Post-Acquisition:
- Total Shares Owned: Previously 7,624,605 ➔ Revised to 7,622,948
- Equity Stake (%): Previously 57.33% ➔ Revised to 57.29%
- Phase 3 Expected Date & Shares: Previously ‘During 2025 (2,267,876 shares)’ ➔ Revised to ‘August 2025 (2,266,219 shares)’
2. Breakdown of Phased Capital Injection
- Phase 1 (Completed): May 30, 2023 / 1,610,413 shares / KRW 207,743M
- Phase 2 (Completed): June 27, 2024 / 1,217,157 shares / KRW 157,013M
- Phase 3 (Scheduled): August 2025 / 2,266,219 shares / KRW 292,342M
3. Overview of Target Company (42dot Inc.)
- Relationship: Subsidiary (In charge of SDV software development for Hyundai Motor Group)
- Purpose of Acquisition: Maintain control and enhance business competitiveness
- Acquisition Method: Cash acquisition (Participation in shareholder rights offering)
- Board Resolution Date: April 25, 2023 (All 7 Outside Directors attended)
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verifying Phase 3 Capital Payment and Subsequent Filings
Because this disclosure reports corrections to 42dot’s rights offering participation due to business plan adjustments, it is necessary to check whether the Phase 3 payment is completed on the revised schedule (August 2025). Confirming the payment execution is essential to accurately tracking the progress of the subsidiary’s capital injection. Relevant details can be verified in upcoming Periodic Reports (Quarterly, Half-Yearly, Annual Reports) or official disclosures.
📢 Disclaimer & Source Notice
Source: This content has been structured and newly drafted based on official data submitted to the Financial Supervisory Service’s DART system.
Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.
Inquiries: For compliance inquiries or copyright-related requests, please contact ksb220805@gmail.com.
